Development of Biomarkers for the Early Detection, Surveillance and Monitoring of Pancreatic Ductal Adenocarcinoma
The purpose of this study is to develop a minimally invasive test to diagnose pancreatic cancer at early stages of disease and monitor response to treatment.
⁃ Cohort 1: Advanced Pancreatic Cancer Cohort Inclusion Criteria
• Radiological, histological or cytological confirmed diagnosis of locally advanced or metastatic pancreatic adenocarcinoma by the enrolling institution
• Patient planning to receive systemic treatment
• Hemoglobin \> 8
• ECOG performance status 0-2
• A minimum age of 18 years old
• Willing to undergo a tumor biopsy
• Willing to provide permission to obtain banked tumor tissue for analysis (previous biopsies or surgical material).
⁃ Cohort 2: Operable Pancreatic Cancer Cohort Inclusion Criteria
• Radiological, histological or cytological confirmed diagnosis of pancreatic adenocarcinoma by the enrolling institution
• Patient planned to undergo upfront resection
• No pre-operative systemic therapy nor chemoradiation therapy planned
• Hemoglobin \> 8
• ECOG performance status 0-2
• A minimum age of 18 years old
• Willing to undergo a tumor biopsy
• Willing to provide permission to obtain banked tumor tissue for analysis (previous biopsies or surgical material).
⁃ Cohort 3: Acute Benign Pancreatic Pathology Control Inclusion Criteria
• Confirmed diagnosis of acute pancreatitis or other acute pancreatic pathology by the enrolling institution
• Hemoglobin \> 8
• ECOG performance status 0-2
• A minimum age of 18 years old
⁃ Cohort 4: Chronic Benign Pancreatic Pathology Control Inclusion Criteria
• Confirmed diagnosis of chronic pancreatitis or other non-cystic chronic pancreatic pathology by the enrolling institution
• Hemoglobin \> 8
• ECOG performance status 0-2
• A minimum age of 18 years old
⁃ Cohort 5: IPMN Control Inclusion Criteria
• Confirmed diagnosis of IPMN without high risk features by the enrolling institution
• A minimum age of 18 years old
⁃ Cohort 6: Pancreatic Cyst Control Inclusion Criteria
• Confirmed diagnosis of benign pancreatic cyst by the enrolling institution
• A minimum age of 18 years old
⁃ Cohort 7: Healthy Control Inclusion Criteria
• A minimum age of 18 years old